Nuclear factor erythroid 2-related factor 2 activation in streptozotocin-induced diabetic rats normalize renal hemodynamics and oxygen consumption

Autor: Patrik Persson

Publikováno v: Upsala Journal of Medical Sciences, Vol 129, Pp 1-6 (2024)

Background: Diabetic kidney disease is a major contributor to end stage renal disease. A change in kidney oxygen homeostasis leading to decreased tissue oxygen tension is an important factor initiating alterations in kidney function in diabetes. Howe

Externí odkaz: https://doaj.org/article/67bcc90bb28943ae8ad3bf04e60aabb3

Relationship of Thyroid Function with Renal Hemodynamics and Cholesterol Metabolism in Proteinuric Kidney Disease: A Pilot Study

Autor: Yoshitaka Iwazu, Kazuhiko Kotani, Taro Sugase, Daisuke Nagata, Toshiyuki Yamada

Publikováno v: Metabolites, Vol 14, Iss 2, p 111 (2024)

Nephrotic syndrome and hypothyroidism are respectively reported to influence renal hemodynamics and hypercholesterolemia. However, the relationship of proteinuria-associated thyroid function with renal hemodynamics and cholesterol metabolism has yet

Externí odkaz: https://doaj.org/article/1fe86bf4b5cd4546bbd4b73c8a7bbdc6

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS)

Autor: Mark M. Smits, Jens J. Holst, D. Margriet Ouwens, Daniël H. van Raalte, Bolette Hartmann, Lennart Tonneijck, Marcel H.A. Muskiet, A.H. Jan Danser, Mark H.H. Kramer, Jaap A. Joles

Publikováno v: Diabetes, Obesity and Metabolism, 24(1), 115-124. Wiley-Blackwell Publishing Ltd
Muskiet, M H A, Tonneijck, L, Smits, M M, Kramer, M H H, Ouwens, D M, Hartmann, B, Holst, J J, Danser, A H J, Joles, J A & van Raalte, D H 2022, ' Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS) : A predefined substudy of a randomized, double-blind trial ', Diabetes, Obesity and Metabolism, vol. 24, no. 1, pp. 115-124 . https://doi.org/10.1111/dom.14557
Diabetes, Obesity and Metabolism, 24(1), 115-124. Wiley-Blackwell

Aim: To determine the effect of the dipeptidyl peptidase-4 inhibitor linagliptin on postprandial glomerular hyperfiltration compared with the sulphonylurea glimepiride in adults with type 2 diabetes (T2D). Materials and Methods: In this predefined su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::534caa9602f0c50db8374da17849d33f
http://www.scopus.com/inward/record.url?scp=85116479294&partnerID=8YFLogxK